Quercetin, known for its hepatoprotective effect on T2DM-associated MASLD, down-regulates nuclear YY1, which directly binds to the CYP7A1 promoter and activates its transcription. The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatotic liver disease.